-
Study aim
-
Determining and comparing the therapeutic effects of intravenous vitamin C injection on laboratory findings in covid-19 patients
-
Design
-
A clinical trial with a control placebo group; parallel groups; single-blind; phase 3; performed on 90 patients; using Random Allocation Software.
-
Settings and conduct
-
The study is a one-sided blind clinical intervention .Initially, 90 patients with covid-19 who were admitted to Taleghani hospital wards were divided into two groups of 45 receiving standard treatment with intravenous vitamin C (intervention group) and receiving only standard treatment (control group).The intervention includes injection of vitamin C in amount of 1.5 gr for each patient in the intervention group by intravenous infusion ,using normal saline 500 cc in 4 hours, at the moment of entering the ward. Both study groups will receive all standard procedures and treatment, equally, but do not know which placebo to inject and which drug.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: Adults (age 18 years or older); SPO2<92%; Being treated in the ward; Positive PCR test; Involvement of Chest-CT-Scan. Exclusion criteria: Patients with a history of allergy to vitamin C; Patients with dyspnea caused by cardiogenic pulmonary edema; Pregnant and Lactating women; Patients with a previous history of end-stage pulmonary disease, end-stage malignant tumor, diabetic ketoacidosis, severe kidney disease; Active kidney stone disease
-
Intervention groups
-
The intervention includes injection of vitamin C in amount of 1.5 gr for each patient in the intervention group by intravenous infusion ,using normal saline 500 cc in 4 hours, at the moment of entering the ward and for control group ,a placebo with the above specification is injected.
-
Main outcome variables
-
WBC ,CRP ,ESR , AST ,ALT ,ALK.P, PT ,PTT ,INR ,LDH ,Ferritin , D-dimer , duration of hospitalization ,death